WOLVERINE ASSET MANAGEMENT LLC - PHOENIX BIOTECH ACQUISITION ownership

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q3 2023$6,293
+17.2%
87,8930.0%0.00%
Q2 2023$5,370
+52.4%
87,8930.0%0.00%
Q1 2023$3,524
-7.0%
87,8930.0%0.00%
Q4 2022$3,788
-36.9%
87,893
+8.9%
0.00%
Q3 2022$6,000
-25.0%
80,6890.0%0.00%
Q2 2022$8,000
-52.9%
80,6890.0%0.00%
Q1 2022$17,000
-48.5%
80,6890.0%0.00%
Q4 2021$33,00080,6890.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,639,0000.08%
Radcliffe Capital Management, L.P. 150,000$1,503,0000.04%
Telemetry Investments, L.L.C. 125,114$13,0000.02%
Q Global Advisors, LLC 170,785$17,0000.01%
Atalaya Capital Management LP 225,000$25,0000.00%
MMCAP International Inc. SPC 375,000$38,0000.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 677,408$88,0000.00%
Alpine Global Management, LLC 55,100$6,0000.00%
Sage Rock Capital Management LP 91,999$9,0000.00%
Bulldog Investors, LLP 51,757$5,0000.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders